NEW YORK, April 03, 2018 -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Akorn, Inc. (NASDAQ:AKRX) who purchased shares between March 1, 2017 and February 26, 2018. The action, which was filed in the United States District Court for the District of Illinois, alleges that the Company violated federal securities laws.
In particular, the complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that (1) the Company’s failure to comply with FDA data integrity requirements would jeopardize Fresenius’ acquisition of the Company; (2) the Company lacked effective internal controls over financial reporting; and (3) as a result, the Company’s financial statements were materially false and misleading at all relevant times.
Shareholders have until May 7, 2018 to petition the court for lead plaintiff status. Your ability to share in any recovery does not require that you serve as lead plaintiff. You may choose to be an absent class member.
If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-c/akorn-inc?wire=3.
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com


Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Telegram Restored on Apple App Store After Temporary Removal
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Vast Eyes Hong Kong IPO as Chinese AI Unicorn Gains Momentum
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Apple Restores Telegram to App Store After Content Policy Violation
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race 



